Editorial: measuring inflammatory and fibrotic components of portal hypertension - a noninvasive hepatic venous pressure gradient?
- PMID: 27296685
- DOI: 10.1111/apt.13667
Editorial: measuring inflammatory and fibrotic components of portal hypertension - a noninvasive hepatic venous pressure gradient?
Comment in
-
Editorial: measuring inflammatory and fibrotic components of portal hypertension - a non-invasive hepatic venous pressure gradient? Authors' reply.Aliment Pharmacol Ther. 2016 Jul;44(2):205-6. doi: 10.1111/apt.13683. Aliment Pharmacol Ther. 2016. PMID: 27296686 No abstract available.
Comment on
-
The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis.Aliment Pharmacol Ther. 2016 Jun;43(11):1222-31. doi: 10.1111/apt.13618. Epub 2016 Apr 7. Aliment Pharmacol Ther. 2016. PMID: 27061098
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
